Description
Recombinant monoclonal antibody to CD45. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma BC8.
Target
CD45
Target Alias Names
Receptor-type tyrosine-protein phosphatase C, L-CA, Leukocyte common antigen, T200, Lymphocyte antigen 5
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression